ライフサイエンスコーパス: similar in

1 rs, and differences were typically larger at older ages and similar in magnitude in each cohort.

2 Contrast sensitivity was high and similar in photopic and mesopic conditions.

3 The results with analogous organolead compounds are similar in that trimethyllead (TML) is not cleaved and binds

4 These four enzymes are similar in their constituent domains, but they fill surprisin

5 Hepatitis C virus (HCV) cure rates have been similar in patients with and without human immunodeficiency v

6 Despite FDO11DFCB3 being similar in chemical structure to the novel materials presente

7 Low-risk-of-bias studies had outcome estimates similar in magnitude and direction to estimates from high-ris

8 Imaging using (18)F-TFB imparts a radiation exposure similar in magnitude to many other (18)F-labeled radiotracers

9 m report outcomes comparable to students who participate in similar in-person programs.

10 anti-C3b/anti-FB Abs and alternative pathway activation is similar in Ig-MPGN and C3G, suggesting similar pathogenic mec

11 he prevalence of AD in longitudinal birth cohort studies is similar in childhood and adolescence/early adulthood.

12 This result was qualitatively similar in the unmatched population (hazard ratio, 0.57; 95%

13 with those of a reference population of 44 healthy subjects similar in age (45.4 +/- 16 y; P = 0.87) and sex (73% women;

14 Slavic speakers of Eastern Europe are, in general, very similar in their genetic composition.

15 results showed that the overall timecourse of adaption was similar in both HMD-VR and CT.

16 Adherence was similar in both groups.

17 The occurrence of anti-drug antibodies was similar in the treatment groups (five [2%] of 268 patients in

18 The chromatographic profile of betalains was similar in SpR, SpO, and SsR, where indicaxanthin, gomphrenin

19 Intracranial pressure control was similar in both groups.

20 in lesional vs nonlesional AD, TCR repertoire diversity was similar in lesional and nonlesional tissues, and absolute num

21 Incidence of adverse events was similar in all groups (43 [88%] of 49 in the TRF-budesonide 1

22 atients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, but th

23 Weight gain was similar in the lower- and higher-protein groups: mean (95% CI

24 The incidence of ALRI hospitalizations was similar in the IIV and placebo group for infants >3 months of

25 Overall survival improvement was similar in patients with squamous (HR 0.73 [95% CI 0.54-0.98]

26 CDI incidence was similar in both exposure groups.

27 l was worse in patients with MVO (P=0.014), although it was similar in patients with and without NR (P=0.33).

28 Occurrence of extra-intestinal manifestations was similar in elderly and adult patients, but bowel surgery was

29 f positive instances in both loading and leakage models was similar in the two databases screened.

30 The number of infant deaths at age 0-6 months was similar in each group (50 in the placebo group and 61 in the

31 After adjustment, 1-year mortality was similar in these patients to that in patients who received TA

32 Alcohol relapse was similar in Group 1 versus Group 2: 23.5% versus 29.2% (P > 0.

33 han 80% of the leukocyte blood gene expression response was similar in male and female patients.

34 But the decomposition of labile SOC was similar in warmed plots compared to the control.

35 ing, diesel vehicle, gasoline vehicle, and dust sources was similar in chemical composition between cities, but PM2.5 fro

36 ffinity nitrogen assimilation enzymes (GS-GOGAT system) was similar in growth-limiting and non-limiting nitrogen concentr

37 s, CKD was associated with an increased risk of HF that was similar in magnitude to CHD and greater than stroke.

38 Rates of HIV viral suppression and adherence to ART were similar in the two groups.

39 Demographic characteristics and hospital courses were similar in both groups, and birth weights ranged from 580 to

40 The rates of renal adverse events were similar in the liraglutide group and the placebo group (15.1

41 Observed frequencies were similar in men and women, with a slight male predominance.

42 Both groups were similar in terms of substantial recanalization (Thrombolysis

43 In addition, the 2 groups were similar in terms of the proportion of patients presenting wit

44 nd that M1 maps of the amputated limb in TMSR patients were similar in terms of extent, strength, and topography to healt

45 ctors, and overexpression of IFN-beta mRNA and protein were similar in MSK1/2 and DUSP1 knockout macrophages.

46 The SPK and LDK recipients were similar in age (41.2 +/- 6.9 years vs 40.5 +/- 10.3 years; P

47 Importantly, CD4(+) T cell responses in vaccinees were similar in magnitude and breadth to those after natural infec

48 The corneal densitometry values were similar in all concentric zones and layers in both groups (P

49 Most clinical variables were similar in the 2 groups; however, there were significantly mo

50 e tissue fractions (MSF), in relation to fresh weight, were similar in both species (E. cyaneus: 0.25 +/- 0.06 mug g(-1);